Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Connect the Dots | Main | Multiple Sclerosis Drug Tysabri Pulled Off Market »

February 25, 2005

Why Are Illusions Fascinating?

Email This Entry

Posted by Zack Lynch

Why do inverted faces lose their emotional meaning? Why do certain types of motion induced blindness? How can a few dots on a screen seem meaningless, but once set in motion become easily recognizable biological creatures?

Everyone, from young children to my 94 year-old grandmother are fascinated by optical illusions. During the 20th century vision science has made significant progress thanks to CRT displays and digital programming. Still, current technologies have inherent limits. For more illusions and to understand the science behind them I highly recommend visiting this amazing website.

Comments (0) + TrackBacks (0) | Category: Perception Shift



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives